The survival time of patients with lung cancer was affected by many factors, and it was difficult to give an exact number. If they did not receive any anti-cancer treatment, they would live for about three to four months on average. Advanced lung cancer was treated with targeted, chemotherapy, immunity, and other anti-tumor treatments. The average overall survival time of most patients was about two years. A small number of patients who were more sensitive to the above-mentioned anti-tumor therapy could achieve complete response and maintain stable progression after treatment. These patients could survive with tumors for a long time, reaching a survival period of five years or longer. According to the relevant research statistics, the reference data for the 5-year survival rate of non-small cell lung cancer in each stage was as follows: the 5-year survival rate of stage I non-small cell lung cancer was 70% - 90%, the 5-year survival rate of stage II was 50% - 70%, the 5-year survival rate of stage III-III was about 36%, 26% and 13% respectively, and the 5-year survival rate of stage IV lung cancer was only about 5%. The results of a national survey in Korea showed that the 5-year survival rate of non-small cell lung cancer was 82% in stage I, 59% in stage I, 16% in stage II, and 10% in stage IV. Regardless of whether it was early or late, the overall 5-year survival rate of small cell lung cancer was 16% in cases of limited diseases and 10% in cases of extensive diseases. The survival time after lung cancer spread was related to the pathological type, the mutation of the driver gene, the location of the tumor, whether it was treated, whether the treatment was standardized, whether the patient had complications, physical condition, age, economic status, and other factors. For example, if the lung cancer had brain metastasizing, if the lung cancer tumor was very small, the tumor in the lung would be one or two centimeters, and there would be no pathological changes. Brain metastasizing was an isolated and relatively small situation. After surgery, radiation therapy, and other treatments, many patients could survive for a long time. They might live for five years, or even ten or twenty years. Some patients with brain metastasizing might only live for a few months. If lung cancer spread to the bones, the patient could live for about six months under normal treatment, but the specific situation varied from person to person. If the patient's general condition was good, and there was only one part of the tumor that had metastasized, or if the metastasized was relatively mild, the patient's survival period might be more than two to three years. If the tumor had metastasized to multiple parts, and the patient could not eat, had anesthesia, consumed a lot of energy, and could not receive radiation and chemotherapy, the patient's survival period might only be a few months. The novel "Ten Years of Death" is equally exciting. Everyone is welcome to click and read it!
The incubation period of the disease could be as long as a few years, and it was even possible for the patient to not get sick for life. The incubation period of lung cancer was usually around 4-8 weeks, but some patients could have an incubation period of 2-3 months. Very few people might have a lifetime incubation period. Everyone's body constitution was different, so the incubation period was quite different. It was recommended to judge according to the specific situation. Lung cancer was a relatively common infectious disease of the lungs. It was highly contagious, with a high mortality rate. Patients with latent period or non-active period usually had no typical symptoms and were not contagious. The characteristics of the latent period also determined the uncertainty of the time of onset. Therefore, there was no fixed time for the incubation period of the disease. It was probably between a few months and a decade. The incubation period of lung cancer depends on the number and toxicity of the infected bacteria, as well as the resistance or immunity of the infected person.
How long a lung tumor could survive after it spread depended on many factors, including the degree of malignant tumor, the extent of spread, the effectiveness of treatment measures, and the patient's physique. The survival time after lung cancer spread was very wide, ranging from a few months to several years. Generally speaking, the less malignant the lung tumor, the longer the patient's survival time. If the spread was limited, the patient could have surgery to remove the tumor to prolong their survival. However, if the tumor spreads widely, especially if distant metastasizing occurs, the patient's survival time will be significantly shortened. Very few patients can live for more than five years. In addition, the effectiveness of the treatment and the patient's physique would also affect the survival time. Some patients with lung cancer could turn lung cancer into a chronic disease through precise targeted therapy, chemotherapy, immune therapy, and anti-inflammatory therapy, and their survival time could reach 3-5 years or even longer. However, for patients with advanced lung cancer, the survival time may be shorter, usually a few months to half a year. In short, the survival time after lung cancer spread varied due to individual differences and many factors. The specific situation needed to be judged according to the patient's specific condition and treatment effect.
If patients with lung cancer could be diagnosed early and receive standard treatment, such as patients who were sensitive to drugs, after standard treatment, the cure rate would be higher, reaching more than 85%. The life expectancy of the cured patients was basically the same as that of normal people. For patients with a second episode, as long as they were treated according to the doctor's advice, the cure rate could reach 70%. However, if the patient was treated irregularly, such as fishing for three days and drying the net for two days, it might cause drug resistance. As the degree of drug resistance increased, the cure rate would gradually decrease, which would greatly threaten the patient's life and health, and might lead to a low five-year survival rate. A small number of patients with lung cancer developed drug resistance during long-term medication, or some older patients developed other serious complications (such as respiratory failure) due to adverse drug reactions. These factors may affect the patient's life expectancy. However, in general, with the development of modern medicine and health care, malaria was a treatable infectious disease. Most patients could be cured with regular treatment and would not affect their lifespan. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The symptoms of getting lung cancer included persistent coughing and expectoration. The coughing lasted for more than two weeks, and the phlegm might be bloodshot. The patient may have a low fever, sweating at night, fever in the afternoon, chest pain, fatigue, weight loss, and difficulty breathing. In addition, the patient may feel fatigue, loss of appetite, and even menstrual imbalance or amputation. If these symptoms appeared, it should be highly suspected that he was suffering from malaria and seek medical attention in time.
The treatment criteria for lung cancer were based on symptoms, imaging, and phlegm tests for acid fast bacilliform bacteria. The symptoms included cough, expectoration, hot flashes, night sweats, etc. If the symptoms disappeared after standardized treatment, it meant that the patient was cured. The main purpose of imaging was to observe the image at the beginning and after the treatment. If there were any signs such as fibers, calcium, proliferations, nodes, and thickened pleura, it could also indicate that the lung was cured. Sputum examination of the acid fast bacili was an effective basis for the diagnosis of lung cancer. If the acid fast bacili in the phlegm turned negative after standardized treatment, and no acid fast bacili was found after multiple examinations, it could also indicate that the lung cancer was cured. Therefore, the criteria for the treatment of lung cancer included clinical symptoms, imaging, and examination of phlegm for acid fast bacilliform bacteria. The whole treatment process was 6-8 months, and the whole treatment process for drug-resistant lung cancer was 18-24 months. Most of the patients with lung cancer could be cured as long as they received standard anti-tumor treatment. However, if the treatment was not standardized, it would lead to treatment failure or even become drug-resistant malaria. The cure rate was low, the treatment cost was high, and the social harm was great. The course of treatment for relapsed lung cancer was significantly longer. Initial treatment usually took about half a year, while relapsed lung cancer took one year or even one and a half years. The adverse drug reactions would also increase, and the damage to the liver and kidney would also increase.
The main treatment method for lung cancer was a combination of anti-inflammatory drugs. Commonly used anti-tb drugs include isoniazid, rifampicin, pyrazinamid, and ethambutal. The treatment time was usually six months or longer, depending on the patient's condition and the doctor's recommendation. The treatment principles were early, regular, full, moderate, and combined. The treatment plan was divided into two stages: the strengthening stage and the consolidation stage. For drug-resistant lung cancer, the medication plan needed to be adjusted according to the results of the smear test and the sensitivity of the cultured strains. During the treatment process, the patient needed to take the medicine regularly to avoid missing the medicine, and follow the doctor's advice to take the medicine and stop the medicine. During the treatment, the patient should pay attention to nutritional support and active rehabilitation exercises. For some patients with serious conditions or complications, the treatment time may be extended appropriately. Surgery could also be considered in some special cases, such as limited multi-drug-resistant chemotherapy. In general, the treatment of lung cancer needed to be based on the patient's specific condition and the doctor's recommendations.
The treatment time for mild cases varies from person to person, and the treatment time may be between six months to two years. For patients with non-drug-resistant primary treatment, the treatment time was usually about six months. However, for patients with chronic underlying diseases, the treatment time may need to be extended to nine months. If it was a re-treated mild form of lung cancer or a drug-resistant strain, treatment usually took 1-2 years. Therefore, the treatment time for mild lung cancer needed to be determined according to the patient's specific condition.
It would take at least half a year to cure it. For patients with newly diagnosed active lung cancer, the treatment plan included an intensive period of two months and a consolidation period of four months. The total course of retreatment for smear-positive lung cancer was 8-12 months. If the phlegm bacteria did not turn negative after four months of treatment during the consolidation period, the treatment period could be extended by 6-10 months. The total duration of treatment for drug-resistant lung cancer was two years or even more than two and a half years. The intensive treatment period was 9-12 months, and the total treatment period was 20 months or longer. The specific treatment time depends on the severity of the infection and the effect of the treatment.
Pathological examination was the "gold standard" for the diagnosis of lung cancer. If the pathological results showed cancer, it could be confirmed to be lung cancer to a large extent. However, pathological diagnosis was affected by many factors, such as the limitations of the tissues sent for examination, the limitations of the diagnosing doctor, and the limitations of medical development. Therefore, there were certain limitations and it was not 100% accurate. However, most of the pathological diagnosis had a certain degree of guidance. If the diagnosis or pathological diagnosis of the local hospital is uncertain, it is recommended to go to a provincial or experienced oncologic hospital for consultation. If conditions permit, a multi-disciplinary diagnosis and treatment (MDT) can also be initiated, which includes various sub-professional treatment experts, pathologists, imaging experts, and other medical professionals related to oncologic treatment. Click on the link below to read the comic "The Fickle President's Exclusive Little Milk Bun"
Lung cancer was a disease that could be cured. Lung cancer could be cured through early, regular, full-course, moderate, and combined treatment. The treatment of lung cancer mainly relied on drugs, and it required the patient to cooperate with supplementary methods such as diet nutrition. According to the relevant doctors, the cure rate of lung cancer could reach more than 90%. Even in the late stages, lung cancer could be cured by actively cooperating with the doctor's treatment plan and persisting in treatment. Therefore, it was a disease that could be cured.